Oncolytics Biotech Files April 2024 6-K Report
Ticker: ONCY · Form: 6-K · Filed: Apr 11, 2024 · CIK: 1129928
| Field | Detail |
|---|---|
| Company | Oncolytics Biotech INC (ONCY) |
| Form Type | 6-K |
| Filed Date | Apr 11, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, foreign-private-issuer
Related Tickers: ONCY
TL;DR
ONCOLYTICS BIOTECH (ONCY) filed its monthly 6-K report on April 11, 2024.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on April 11, 2024, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and operates in the Pharmaceutical Preparations industry. This filing is for the month of April 2024 and is submitted under the 1934 Securities Exchange Act.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Oncolytics Biotech Inc.'s status as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain significant new financial or operational information that would immediately alter risk.
Key Players & Entities
- ONCOLYTICS BIOTECH INC (company) — Filer of the 6-K report
- April 2024 (date) — Reporting period for the 6-K
- 001-38512 (other) — Commission File Number for Oncolytics Biotech Inc.
- Calgary, Alberta, Canada (location) — Principal executive offices of the company
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, providing information that the registrant makes or is required to make public pursuant to the laws of its home country, or is required to publish or is about to publish or has made or is about to make public.
What is the filing date of this Form 6-K?
This Form 6-K was filed on April 11, 2024.
What is the reporting period for this Form 6-K?
The reporting period for this Form 6-K is the month of April 2024.
Where is Oncolytics Biotech Inc. headquartered?
Oncolytics Biotech Inc. is headquartered in Calgary, Alberta, Canada, with its principal executive offices located at Suite 804, 322 11th Avenue SW, Calgary, Alberta, Canada T2R 0C5.
Does Oncolytics Biotech Inc. file an annual report on Form 20-F or 40-F?
Oncolytics Biotech Inc. indicates that it files its annual reports under cover of Form 20-F.
Filing Stats: 334 words · 1 min read · ~1 pages · Grade level 17.1 · Accepted 2024-04-11 10:03:48
Filing Documents
- form6ktypecmeetingrequest.htm (6-K) — 18KB
- typecmeeting.htm (EX-99.1) — 15KB
- 0001129928-24-000022.txt ( ) — 34KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Oncolytics Biotech Inc. (Registrant) By s Kirk Look Date April 11, 2024 Kirk Look Chief Financial Officer